Pacific Biosciences of California (PACB) News Today $1.68 +0.10 (+5.97%) As of 02:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic CapabilitiesOctober 14 at 6:05 AM | globenewswire.comPacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome ProjectOctober 13 at 9:05 AM | globenewswire.comWeiss Ratings Reiterates Sell (E+) Rating for Pacific Biosciences of California (NASDAQ:PACB)October 10, 2025 | marketbeat.comWhy Is PacBio (PACB) Stock Soaring TodayOctober 8, 2025 | msn.comLong Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional LongevityOctober 8, 2025 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Passes Above 200-Day Moving Average - Here's WhyOctober 8, 2025 | marketbeat.comPacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More LabsOctober 7, 2025 | globenewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 30, 2025 | marketbeat.comPacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging GenesSeptember 22, 2025 | globenewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) is favoured by institutional owners who hold 64% of the companySeptember 21, 2025 | finance.yahoo.comPacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10, 2025 | seekingalpha.comNuveen LLC Invests $319,000 in Pacific Biosciences of California, Inc. $PACBSeptember 8, 2025 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Hold" by AnalystsSeptember 7, 2025 | marketbeat.comInvesco Ltd. Raises Stake in Pacific Biosciences of California, Inc. $PACBSeptember 7, 2025 | marketbeat.comPacific Biosciences of California, Inc. $PACB Shares Bought by Edmond DE Rothschild Holding S.A.September 6, 2025 | marketbeat.comPacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq WorkflowSeptember 3, 2025 | globenewswire.comVanguard Group Inc. Has $19.19 Million Stake in Pacific Biosciences of California, Inc. $PACBSeptember 1, 2025 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Pass Above 200-Day Moving Average - Time to Sell?August 28, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Sells 215,632 Shares of Pacific Biosciences of California, Inc. $PACBAugust 20, 2025 | marketbeat.comPacBio (PACB) Shares Skyrocket, What You Need To KnowAugust 14, 2025 | msn.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comPiper Sandler Issues Positive Forecast for Pacific Biosciences of California (NASDAQ:PACB) Stock PriceAugust 12, 2025 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Hold" from BrokeragesAugust 12, 2025 | marketbeat.comPACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive ResultsAugust 11, 2025 | finance.yahoo.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Just Released Its Second-Quarter Earnings: Here's What Analysts ThinkAugust 10, 2025 | finance.yahoo.comKoss Olinger Consulting LLC Has $3.54 Million Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)August 10, 2025 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comPacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comPacBio (PACB) Stock Trades Up, Here Is WhyAugust 8, 2025 | msn.comPacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock SoarsAugust 8, 2025 | msn.comJackson Square Partners LLC Sells 1,788,905 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)August 8, 2025 | marketbeat.comPACB Sales Up 11%August 7, 2025 | fool.comXTX Topco Ltd Takes $576,000 Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)August 7, 2025 | marketbeat.comPacific Biosciences of California (PACB) Q2 Earnings PreviewAugust 6, 2025 | gurufocus.comPacific Biosciences of California Q2 2025 Earnings PreviewAugust 6, 2025 | seekingalpha.comPacBio to Present at Upcoming Investor ConferencesAugust 6, 2025 | globenewswire.comPacBio (PACB) Q2 Earnings Report Preview: What To Look ForAugust 6, 2025 | msn.comNature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI ModelsAugust 4, 2025 | globenewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)August 4, 2025 | marketbeat.comBank of New York Mellon Corp Has $1.02 Million Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)August 1, 2025 | marketbeat.comPacific Biosciences of California (PACB) Projected to Post Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading 9.4% Higher - What's Next?July 29, 2025 | marketbeat.comEven after rising 13% this past week, Pacific Biosciences of California (NASDAQ:PACB) shareholders are still down 63% over the past three yearsJuly 29, 2025 | finance.yahoo.comPacific Biosciences (PACB) Jumps 6.5% Ahead of EarningsJuly 29, 2025 | insidermonkey.comAthena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene SequencingJuly 29, 2025 | prnewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by ARK Investment Management LLCJuly 27, 2025 | marketbeat.comWhy PacBio (PACB) Stock Is Up TodayJuly 24, 2025 | msn.comPacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature CommunicationsJuly 24, 2025 | globenewswire.comPacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game ChangerJuly 23, 2025 | seekingalpha.comPacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and RevioJuly 23, 2025 | globenewswire.com Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PACB Media Mentions By Week PACB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.290.72▲Average Medical News Sentiment PACB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼64▲PACB Articles Average Week Get the Latest News and Ratings for PACB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pacific Biosciences of California and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TXG News Today HBIO News Today TMO News Today A News Today MTD News Today WAT News Today ILMN News Today TECH News Today CRL News Today BIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
